In a recent survey, findings reveal that nearly half of the companies in the healthcare supply chain sector (46%) are utilizing artificial intelligence (AI) to proactively identify and address potential disruptions in their supply chains.
Published on January 16 in the “Trade in Transition 2024” report by the business intelligence think tank Economist Impact, the study highlights the growing role of AI in the healthcare industry. According to the survey, 44% of healthcare organizations are leveraging AI to enhance customer experiences, while an additional 35% are using this technology to forecast consumer demands.
The adoption of AI in the healthcare supply chain is proving to be a strategic move, with 34% of survey participants reporting a reduction in the overall cost of trade operations attributed to AI implementation. Furthermore, 32% noted that AI has played a pivotal role in minimizing supply chain disruptions.
Magrietha Mallinson, the global vertical lead of Health at DP World, the company that supported the study, emphasized the importance of embracing advanced technologies in the current unpredictable business landscape. Mallinson stated, “In an era where unpredictability is the new constant, leveraging advanced technologies like AI is imperative. As production methods and pharmaceutical products continue to become more advanced, the industry must seek to innovate at every stage of the supply chain.”
The “Trade in Transition 2024” survey, which gathered insights from 3,500 senior executives globally, underscores the critical role AI plays in fortifying healthcare supply chains. As the industry evolves with advanced technologies, the proactive use of AI emerges as a key driver for innovation and resilience in meeting the challenges of an ever-changing global market.
